Literature DB >> 20042627

Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site.

Andrew T Carter, David R Mason, Kathie A Grant, Giovanna Franciosa, Paulo Aureli, Michael W Peck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20042627      PMCID： PMC2832408          DOI： 10.1128/JCM.01774-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  11 in total

1.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

Review 2.  Transcriptional interference--a crash course.

Authors:  Keith E Shearwin; Benjamin P Callen; J Barry Egan
Journal:  Trends Genet       Date:  2005-06       Impact factor: 11.639

3.  BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani.

Authors:  Stéphanie Raffestin; Bruno Dupuy; Jean Christophe Marvaud; Michel R Popoff
Journal:  Mol Microbiol       Date:  2005-01       Impact factor: 3.501

Review 4.  Regulation of toxin and bacteriocin synthesis in Clostridium species by a new subgroup of RNA polymerase sigma-factors.

Authors:  Bruno Dupuy; Susana Matamouros
Journal:  Res Microbiol       Date:  2005-12-29       Impact factor: 3.992

5.  Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes.

Authors:  Nir Dover; Jason R Barash; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  A case of infant botulism with a possible link to infant formula milk powder: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food.

Authors:  M M Brett; J McLauchlin; A Harris; S O'Brien; N Black; R J Forsyth; D Roberts; F J Bolton
Journal:  J Med Microbiol       Date:  2005-08       Impact factor: 2.472

Review 7.  Biology and genomic analysis of Clostridium botulinum.

Authors:  Michael W Peck
Journal:  Adv Microb Physiol       Date:  2009       Impact factor: 3.517

8.  Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains.

Authors:  Giovanna Franciosa; Antonella Maugliani; Concetta Scalfaro; Paolo Aureli
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

9.  Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.

Authors:  Andrew T Carter; Catherine J Paul; David R Mason; Susan M Twine; Mark J Alston; Susan M Logan; John W Austin; Michael W Peck
Journal:  BMC Genomics       Date:  2009-03-19       Impact factor: 3.969

10.  Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.

Authors:  Theresa J Smith; Karen K Hill; Brian T Foley; John C Detter; A Christine Munk; David C Bruce; Norman A Doggett; Leonard A Smith; James D Marks; Gary Xie; Thomas S Brettin
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240
View more
  8 in total

1.  Rapid affinity immunochromatography column-based tests for sensitive detection of Clostridium botulinum neurotoxins and Escherichia coli O157.

Authors:  Jason Brunt; Martin D Webb; Michael W Peck
Journal:  Appl Environ Microbiol       Date:  2010-04-30       Impact factor: 4.792

2.  Identical novel A5(B3') botulinum neurotoxin gene arrangements isolated from widely disparate geographical and patient sources suggest their independent origins.

Authors:  Nir Dover; Jason R Barash; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2010-05       Impact factor: 5.948

3.  Subtyping botulinum neurotoxins by sequential multiple endoproteases in-gel digestion coupled with mass spectrometry.

Authors:  Dongxia Wang; Jakub Baudys; Jon Rees; Kristin M Marshall; Suzanne R Kalb; Bryan A Parks; Louis Nowaczyk; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2012-05-21       Impact factor: 6.986

4.  Complete genome sequence of the proteolytic Clostridium botulinum type A5 (B3') strain H04402 065.

Authors:  Andrew T Carter; Bruce M Pearson; Lisa C Crossman; Nizar Drou; Darren Heavens; David Baker; Melanie Febrer; Mario Caccamo; Kathie A Grant; Michael W Peck
Journal:  J Bacteriol       Date:  2011-03-04       Impact factor: 3.490

5.  Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

Authors:  Theresa J Smith; Karen K Hill; Gary Xie; Brian T Foley; Charles H D Williamson; Jeffrey T Foster; Shannon L Johnson; Olga Chertkov; Hazuki Teshima; Henry S Gibbons; Lauren A Johnsky; Mark A Karavis; Leonard A Smith
Journal:  Infect Genet Evol       Date:  2014-12-06       Impact factor: 3.342

Review 6.  Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II.

Authors:  Andrew T Carter; Michael W Peck
Journal:  Res Microbiol       Date:  2014-11-04       Impact factor: 3.992

7.  Draft Genome Sequence of Clostridium botulinum Subtype bont/A5(B2').

Authors:  Ana Rafaela Kruemmel; Jessica L Halpin; Victoria Foltz; Janet Dykes; Carolina Lúquez
Journal:  Microbiol Resour Announc       Date:  2022-06-27

8.  Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Authors:  Christelle Mazuet; Christine Legeay; Jean Sautereau; Laurence Ma; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  Genome Biol Evol       Date:  2016-06-13       Impact factor: 3.416
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.